Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Century City Docotrs Hospital
1981
mi
from 43215
Los Angeles, CA
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Century City Docotrs Hospital
1981
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
University of Colorado Health
1159
mi
from 43215
Denver, CO
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
University of Colorado Health
1159
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
The University of Michigan HS
164
mi
from 43215
Ann Arbor, MI
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
The University of Michigan HS
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
CHCS - Carolinas Medical Center
350
mi
from 43215
Charlotte, NC
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
CHCS - Carolinas Medical Center
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Carolina Urologic Research Center
487
mi
from 43215
Myrtle Beach, SC
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Carolina Urologic Research Center
487
mi
from 43215
Myrtle Beach, SC
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Centennial Hospital
334
mi
from 43215
Nashville, TN
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Centennial Hospital
334
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Baylor College of Medicine
991
mi
from 43215
Houston, TX
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Christus Santa Rosa Hospital
1138
mi
from 43215
San Antonio, TX
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Christus Santa Rosa Hospital
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Norfolk General
422
mi
from 43215
Norfolk, VA
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Norfolk General
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated:  1/3/2018
Sunnybrook Health Sciences Centre
316
mi
from 43215
Toronto,
A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
A Pre-Market Study of the AMS Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence
Status: Enrolling
Updated: 1/3/2018
Sunnybrook Health Sciences Centre
316
mi
from 43215
Toronto,
Click here to add this to my saved trials
A Feasibility Device Study to Prevent Female Urinary Stress Incontinence
Randomized, Crossover Feasibility Study of a Device to Prevent Female Urinary Stress Incontinence
Status: Enrolling
Updated:  1/4/2018
University of Oklahoma Health Sciences Center
841
mi
from 43215
Oklahoma City, OK
A Feasibility Device Study to Prevent Female Urinary Stress Incontinence
Randomized, Crossover Feasibility Study of a Device to Prevent Female Urinary Stress Incontinence
Status: Enrolling
Updated: 1/4/2018
University of Oklahoma Health Sciences Center
841
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated:  1/8/2018
Birmingham VAMC
492
mi
from 43215
Birmingham, AL
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated: 1/8/2018
Birmingham VAMC
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated:  1/8/2018
Atlanta VA Medical Center
430
mi
from 43215
Decatur, GA
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
Status: Enrolling
Updated: 1/8/2018
Atlanta VA Medical Center
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Maricopa Integrated Health Systems
1662
mi
from 43215
Phoenix, AZ
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Maricopa Integrated Health Systems
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
University of California, Irvine Medical Center
1958
mi
from 43215
Orange, CA
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
University of California, Irvine Medical Center
1958
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
The Hartford Hospital
554
mi
from 43215
Hartford, CT
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
The Hartford Hospital
554
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Altus Research
938
mi
from 43215
Lake Worth, FL
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Altus Research
938
mi
from 43215
Lake Worth, FL
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
University Of South Florida Medical Center
822
mi
from 43215
Tampa, FL
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
University Of South Florida Medical Center
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Boston Clinical Trials, INC.
643
mi
from 43215
Boston, MA
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Boston Clinical Trials, INC.
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Accumed Research Associates
496
mi
from 43215
Garden City, NY
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Accumed Research Associates
496
mi
from 43215
Garden City, NY
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Lyndhurst Gynecological Associates
306
mi
from 43215
Winston-Salem, NC
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Lyndhurst Gynecological Associates
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Temple University
416
mi
from 43215
Philadelphia, PA
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Temple University
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Jackson Clinic, PA
436
mi
from 43215
Jackson, TN
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Jackson Clinic, PA
436
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated:  1/17/2018
Renaissance Health & Surgical Associates
372
mi
from 43215
South Pittsburg, TN
Neurotech Vital Compact Versus Itouch Sure Pelvic Floor Exerciser US
A Single-blind, Multi-centre, Randomised, Controlled, Non-inferiority, Clinical Study to Assess the Safety and Performance of the Neurotech Vital Compact Device Compared to the Itouch Sure Pelvic Floor Exerciser for the Treatment of Stress Urinary Incontinence in Female Patients
Status: Enrolling
Updated: 1/17/2018
Renaissance Health & Surgical Associates
372
mi
from 43215
South Pittsburg, TN
Click here to add this to my saved trials
Urodynamic Testing: Can we Improve Patient Experience?
A Telephone Call to Decrease Patient Anxiety Before Urodynamic Testing: a Randomized Controlled Trial
Status: Enrolling
Updated:  1/17/2018
Mount Auburn Hospital
639
mi
from 43215
Cambridge, MA
Urodynamic Testing: Can we Improve Patient Experience?
A Telephone Call to Decrease Patient Anxiety Before Urodynamic Testing: a Randomized Controlled Trial
Status: Enrolling
Updated: 1/17/2018
Mount Auburn Hospital
639
mi
from 43215
Cambridge, MA
Click here to add this to my saved trials
Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?
Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?
Status: Enrolling
Updated:  1/26/2018
The Christ Hospital
98
mi
from 43215
Cincinnati, OH
Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?
Can Investigators Reduce Urinary Catheter Use and Lower Urinary Tract Infection Among Women Undergoing Benign Gynecologic Surgery?
Status: Enrolling
Updated: 1/26/2018
The Christ Hospital
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
Acupuncture for Female Interstitial Cystitis/Painful Bladder Syndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
Status: Enrolling
Updated:  1/31/2018
Loyola University Medical Center
283
mi
from 43215
Maywood, IL
Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
Acupuncture for Female Interstitial Cystitis/Painful Bladder Syndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial
Status: Enrolling
Updated: 1/31/2018
Loyola University Medical Center
283
mi
from 43215
Maywood, IL
Click here to add this to my saved trials
Bladder Environment: Microbiome Oxygen Relationship
Bladder Environment: Microbiome Oxygen Relationship
Status: Enrolling
Updated:  2/19/2018
Loyola University Health System
284
mi
from 43215
Maywood, IL
Bladder Environment: Microbiome Oxygen Relationship
Bladder Environment: Microbiome Oxygen Relationship
Status: Enrolling
Updated: 2/19/2018
Loyola University Health System
284
mi
from 43215
Maywood, IL
Click here to add this to my saved trials
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.
Status: Enrolling
Updated:  3/1/2018
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.
Status: Enrolling
Updated: 3/1/2018
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.
Status: Enrolling
Updated:  3/1/2018
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
A Parallel, Double-blind Comparison of Tolterodine vs. Placebo Treatments for Nocturia in Postmenopausal Women.
Status: Enrolling
Updated: 3/1/2018
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery: Randomized Controlled Trial
Status: Enrolling
Updated:  3/1/2018
Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery: Randomized Controlled Trial
Status: Enrolling
Updated: 3/1/2018
Henry Ford Hospital
166
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery: Randomized Controlled Trial
Status: Enrolling
Updated:  3/1/2018
Henry Ford West Bloomfield Hospital
178
mi
from 43215
West Bloomfield, MI
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
The Impact of Retzius-sparing Approach for Robot-assisted Laparoscopic Radical Prostatectomy on Short-term Continence Recovery: Randomized Controlled Trial
Status: Enrolling
Updated: 3/1/2018
Henry Ford West Bloomfield Hospital
178
mi
from 43215
West Bloomfield, MI
Click here to add this to my saved trials
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Status: Enrolling
Updated:  3/7/2018
UAB Continence Clinic at The Kirklin Clinic
492
mi
from 43215
Birmingham, AL
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Vitamin D Supplementation in Older Adults With Urinary Incontinence
Status: Enrolling
Updated: 3/7/2018
UAB Continence Clinic at The Kirklin Clinic
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Pressure-Volume Measurements on the AMS 800TM Cuff
Pressure-Volume Measurements on the AMS 800TM Cuff
Status: Enrolling
Updated:  3/9/2018
University of Minnesota Medical Center
623
mi
from 43215
Minneapolis, MN
Pressure-Volume Measurements on the AMS 800TM Cuff
Pressure-Volume Measurements on the AMS 800TM Cuff
Status: Enrolling
Updated: 3/9/2018
University of Minnesota Medical Center
623
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
An Open Label Study to Measure the Efficacy of Fesoterodine (Toviaz) on Continued Detrusor Overactivity in Patients That Have Undergone Treatment for Bladder Outlet Obstruction
Status: Enrolling
Updated:  3/12/2018
New York Hospital, Cornell University
477
mi
from 43215
New York, NY
An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia
An Open Label Study to Measure the Efficacy of Fesoterodine (Toviaz) on Continued Detrusor Overactivity in Patients That Have Undergone Treatment for Bladder Outlet Obstruction
Status: Enrolling
Updated: 3/12/2018
New York Hospital, Cornell University
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Status: Enrolling
Updated:  3/13/2018
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Status: Enrolling
Updated: 3/13/2018
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
1639
mi
from 43215
Tucson, AZ
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
1930
mi
from 43215
Murrieta, CA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
1930
mi
from 43215
Murrieta, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
789
mi
from 43215
Shreveport, LA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
789
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
457
mi
from 43215
Edison, NJ
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
457
mi
from 43215
Edison, NJ
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
494
mi
from 43215
Homewood, AL
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
494
mi
from 43215
Homewood, AL
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
1981
mi
from 43215
Sherman Oaks, CA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
1981
mi
from 43215
Sherman Oaks, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
545
mi
from 43215
Farmington, CT
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
545
mi
from 43215
Farmington, CT
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
528
mi
from 43215
Middlebury, CT
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
528
mi
from 43215
Middlebury, CT
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Site 9013
158
mi
from 43215
Noblesville, IN
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Site 9013
158
mi
from 43215
Noblesville, IN
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
572
mi
from 43215
West Des Moines, IA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
572
mi
from 43215
West Des Moines, IA
Click here to add this to my saved trials